Brief: Aquestive Therapeutics Inc Received Notice Of Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
03/01/2023 18:45
Jan 3 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS INC - ON DEC 30, 2022, CO RECEIVED NOTICE OF
FAILURE TO
SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma